Results 181 to 190 of about 84,062 (308)

Efficiency of behaviour support interventions for smokeless tobacco cessation by dentists. [PDF]

Subst Abuse Treat Prev Policy
Priyadarshini SR, Pradhan S, Sahu S, Sahoo PK.   +3 more
europepmc   +1 more source

Tobacco cessation: An Indian perspective

Indian Journal of Psychiatric Nursing, 2016
M. Vijayarani, G. Balamurugan, Nagarajaiah   +2 more
openaire   +2 more sources

Barriers and facilitators to detoxification from opioid substitution treatment: A mixed‐methods systematic review

Addiction, EarlyView.
Abstract Background and aims Despite the well‐documented benefits of opioid substitution treatment (OST) in treating opioid dependence (OD), many people diagnosed with OD desire to live a drug‐free life. The transition to abstinence involves detoxification: a gradual dose reduction of OST to zero milligrams.
Amy Bagshaw, Suleyman Shah, India Olchefske, Louise M. Paterson, Mike J. Crawford, Anne Lingford‐Hughes   +5 more
wiley   +1 more source

Quality Assessment of Guidelines on Tobacco Cessation: A Systematic Review. [PDF]

Tob Use Insights
Bhadauria US, Sachdeva A, Priya H, Chawla A, Chahar P, Singh RJ.   +5 more
europepmc   +1 more source

Mobile Health Technology for Personalized Tobacco Cessation Support in Laos (Project Support Laos): Protocol for a Randomized Controlled Trial. [PDF]

JMIR Res Protoc
Bui TC, Xangsayarath P, Keopraseuth P, Phandouangsy K, Keothongkou K, Dittaphong V, Moriasi C, Doan KT, Kulkarni S, Soulaphy C, Xayavong D, Sangxayalath V, Sengdara K, Businelle MS, Frank-Pearce SG, Vidrine JI, Vidrine DJ.   +16 more
europepmc   +1 more source

Factors associated with the percentage of individuals who initiate and discontinue naltrexone as a relapse prevention pharmacotherapy in opioid use disorder: A systematic review, meta‐analysis and meta‐regression

Addiction, EarlyView.
Abstract Background and aims Naltrexone is a pharmacotherapeutic option for relapse prevention in opioid use disorder (OUD); however, studies highlight low rates of initiation and high rates of discontinuation as limiting its effectiveness. We aimed to (1) estimate the percentage of individuals with OUD who (having undergone withdrawal and wish to ...
Emmert Roberts, Elizabeth Sanderson, Thomas Santo Jr., Matthew Hickman, Michael Farrell, Louisa Degenhardt   +5 more
wiley   +1 more source

Determining the impact of cannabis use on tobacco cessation: Results from a prospective non-randomized tobacco treatment trial. [PDF]

Addiction
McClure EA, Baker N, Tomko RL, Walters KJ, Chapman E, Carpenter MJ, Gray KM.   +6 more
europepmc   +1 more source

Prevalence and risk perceptions of nicotine pouch use: A systematic review of population‐based studies

Addiction, EarlyView.
Abstract Background and Aims Oral nicotine pouches (NPs) are a new class of non‐combustible nicotine products that have gained rapid popularity. Despite rising sales and marketing, evidence of their prevalence and risk perceptions remains limited. This systematic review aimed to synthesize the available global evidence on the prevalence and patterns of
Salma Mahmoodianfard, Spencer Shahen, Javad Heshmati, Emma Bates, Evyanne Quirouette, Terefe Gelibo, Sarah Visintini, Hassan Mir   +7 more
wiley   +1 more source

Gaps and Barriers Among Dental Undergraduates Towards Promoting and Assisting Tobacco Cessation: A Multicountry Cross-Sectional Study. [PDF]

Int J Dent
Gopinath D, Ramzi NH, Hettiarachchi PVKS, Pullishery F, Sufiawati I, Podder A, Hashir S, Shrestha A.   +7 more
europepmc   +1 more source

Beyond abstinence: Redefining success in cannabis use disorder treatment

Addiction, EarlyView.
Abstract Background Over two decades of pharmacotherapy research has yet to yield a consistently effective medication for cannabis use disorder (CUD), in part because clinical trials have frequently prioritized abstinence as a primary or key endpoint.
Tobias B. Atkin, Frances R. Levin, John Mariani, Christina A. Brezing   +3 more
wiley   +1 more source